Lindsey Carr, Editor

Katie Huffling, DNP, RN, CNM, FAAN, sits down to discuss her presentation at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference in Houston, Texas from September 28 to October 2022.

For World Menopause Month, we revisit some of this year’s top menopause articles.

An advisory panel for the US Food and Drug Administration voted 14-1 to withdraw 17α-hydroxyprogesterone caproate (Makena; Covis Pharma) from the market.

Research in Menopause connects history of physical/sexual abuse, financial instability with worse menopausal symptoms and overall wellbeing at midlife.

Katie Huffling, DNP, RN, CNM, FAAN, shares how you can help educate your pregnant patients to become more educated consumers.

A look at what's coming to Contemporary OBGYN this week.

The controversial 17α-hydroxyprogesterone caproate (17-OHPC; Makena) showed to be ineffective at preventing preterm birth, according to briefing documents.

A presentation at the North American Menopause Society Annual Meeting outlined the approval status and effectiveness of various pharmacologic treatments of vasomotor symptoms.

In a presentation at the North American Menopause Society Annual Meeting, a study found that women may be more inclined to gain weight during the menopause transition.

The US Food & Drug Administration approved tetanus toxoid, reduced diptheria toxoid and acellular pertussis vaccine, adsorbed [Tdap] (Boostrix, GSK) today for immunization during the third trimester of pregnancy to prevent pertussis—or whooping cough—in infants under 2 months of age.

Amy Levi, CNM, WHNP-BC, FACNM, FAAN, Albers Endowed Professor of Midwifery at the University of New Mexico College of Nursing, sits down to discuss her presentation at the NPWH 25th Annual Premier Women's Healthcare Conference on medications for early pregnancy loss.

Anne Moore, DNP, WHNP/ANP-BC, FAANP, sat down to talk about a new drug combination for COCs.

Amy Levi, CNM, WHNP-BC, FACNM, FAAN, Albers Endowed Professor of Midwifery at the University of New Mexico College of Nursing, sits down to discuss her presentation at the NPWH 25th Annual Premier Women's Healthcare Conference on medications for early pregnancy loss.

Lois McGuire, MSN, APRN, WHNP-BC, NCMP, shared her expertise in perimenopausal contraception during the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Premier Women’s Health Conference, held in Houston, Texas from September 28 to October 2, 2022.

Genevieve Hoffman, DNP, WHNP-BC, sat down to share key highlights from her presentation on menopausal care at the NPWH 25th Annual Premier Women's Healthcare Conference.

Lois McGuire, MSN, APRN, WHNP-BC, NCMP, shared her expertise in perimenopausal contraception during the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Premier Women’s Health Conference, held in Houston, Texas from September 28 to October 2, 2022.

A plenary session presented at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Premier Women’s Healthcare Conference explored how different pharmacological treatment options can help patients with obesity and weight loss management.

Women in the United States go undiagnosed with endometriosis for an average of 10 years before receiving a proper diagnosis. Self-reported screening may be the answer, according to a poster presentation at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference in Houston, Texas from September 28 to October 2022.

An improved electronic health record tracking and reminder system improves patient follow-up after abnormal Pap results and increases compliance with ASCCP guidelines, according to a poster presentation at the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Conference in Houston, Texas from September 28 to October 2022.

In this episode of Pap Talk, Amy Levi, CNM, WHNP-BC, FACNM, FAAN, Albers Endowed Professor of Midwifery at the University of New Mexico College of Nursing, sits down to discuss her presentation at the NPWH 25th Annual Premier Women's Healthcare Conference on medications for early pregnancy loss.

The National Association of Nurse Practitioners in Women’s Health (NPWH) begins their 25th Annual Premier Women’s Healthcare Conference today in Houston, Texas, which will continue until Sunday, October 2, 2022. Follow along for coverage.

What's coming to Contemporary OBGYN this week?

Take a look at this month's top headlines.

Take a look back at the week's news.

Take a look back at the week's news.

A look back at the week's news.

Marina Sirota, PhD, associate professor of pediatrics at the University of California, San Francisco, spoke about the new March of Dimes Prematurity Research Center at UCSF and the impact they hope their research will have on the future of preterm birth.

Take a look back at our most popular stories from August 2022.

Trigger bans took effect on Thursday, August 25, 2022, in Tennessee, Idaho, and Texas, banning abortion from conception in Tennessee and Idaho and enacting harsher penalties for providers in Texas.

More women are using medical cannabis for menopause-related symptoms, according to research recently published in Menopause.